Knee joint replacement follow up study in patients with knee osteoarthritis which participated to the CL3-12911-018 study.

• Conditions: OsteoarthritisThe medical condition investigated in the CL3-12911-018 study was osteoarthritis. The applied CL3-12911-040 trial, CL3-12911-018 follow-up study, is thus performed in osteoarthritic patients.; MedDRA version: 14.1Level: PTClassification code 10031161Term: OsteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2011-004046-18-PL
• Lead Sponsor: Institut de Recherches Internationales Servier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-22
• Last Update Posted: 7 October 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 1202

Inclusion Criteria

Patients included in the CL3-12911-018 study and having received the CL3-12911-018 study treatment (Strontium Ranelate 1g/2g or placebo) for at least one year (at least 365 days of treatment during the CL3-12911-018 study).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 772
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 434

Exclusion Criteria

- unlikely to cooperate in the study (such as patients suffering from dementia)
- patients unable to provide the information requested by the study
- refusal to provide the study's informed consent.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified